Forbes September 12, 2019
David Shaywitz

I’m deeply skeptical that I have much knowledge to impart to Harvard Business School (HBS) students. After all, they’re the ones clever enough to pursue a two year advanced degree (“six months of education crammed into two years,” they joke), while across town, my classmates and I ran gels, plated cells, memorized structures, and took call for a decade or more (in some cases) — and all for the privilege of eventually working for our fleece-vested colleagues (see also this 2011 Scott Gottlieb piece, and my 2012 Forbes post).

Even so, I was recently invited to appear as a guest on a new podcast out of HBS called “Under The Datascope,” where I answered questions about my experiences and perspective...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Pharma, Physician, Precision Medicine, Provider, Technology
109 hospitals receiving new Medicare-backed residency slots
STAT+: UnitedHealth pays its own physician groups considerably more than others, driving up consumer costs and its profits
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Senators urge Congress to avert Medicare physician pay cut
New study offers insights into reliable Alzheimer's diagnosis

Share This Article